Salmonella typhimurium A1-R tumor targeting in immunocompetent mice is enhanced by a traditional Chinese medicine herbal mixture.

Salmonella typhimurium A1-R tumor targeting in immunocompetent mice is enhanced by a traditional Chinese medicine herbal mixture.
复制标题

DOI:
--
复制
发表时间:
2013-05
影响因子:
2
通讯作者:
Yong Zhang;N. Zhang;S. Su;R. Hoffman;Ming Zhao
Yong Zhang;N. Zhang;S. Su;R. Hoffman;Ming Zhao
中科院分区:
医学4区
文献类型:
--
作者:
Yong Zhang;N. Zhang;S. Su;R. Hoffman;Ming Zhao

文献摘要

相似文献

我们已经开发了一种使用基因工程菌株鼠伤寒沙门氏菌A1-R(A1-R)的细菌癌症治疗策略。A1-R是亮氨酸和精氨酸的营养缺陷型,其减弱正常组织中的细菌生长,但允许高肿瘤毒力。A1-R在临床相关的裸鼠模型中对转移性人和鼠癌细胞系有效。然而,高剂量的A1-R治疗免疫活性小鼠模型中的肿瘤受到毒性的限制。目前的研究评估了一种传统的中药(TCM)草药混合物与A1-R治疗相结合的高侵袭性肺癌的同基因转移性免疫活性小鼠模型。在刘易斯肺癌模型中,中药混合物和S.鼠伤寒沙门氏菌A1-R使细菌能够安全地以2 × 10(7)菌落形成单位的大剂量每周一次i. v.给药,与A1-R单药治疗相比,疗效增加,毒性降低。草药混合物防止体重减轻,脾脏重量增加和A1-R引起的肝脏感染,以及皮肤,肝脏和脾脏上的出血性病变,所有这些都是在A1-R单药治疗中观察到的。本研究的结果表明,A1-R和TCM的组合具有重要的潜力,用于治疗高度侵袭性类型的癌症,包括那些对标准治疗有抵抗力的癌症。
We have developed a bacterial cancer therapy strategy using the genetically-engineered strain Salmonella typhimurium A1-R (A1-R). A1-R is auxotrophic for leu and arg which attenuates bacterial growth in normal tissue but allows high tumor virulence. A1-R is effective against metastatic human and murine cancer cell lines in clinically-relevant nude-mouse models. However, A1-R treatment of tumors in immunocompetent mouse models with high doses is limited by toxicity. The current study evaluated a traditional Chinese medicine (TCM) herbal mixture in combination with A1-R therapy in a syngeneic metastatic immunocompetent mouse model of highly aggressive lung cancer. In a model of Lewis lung carcinoma, the combination of a TCM herbal mixture and S. typhimurium A1-R enabled bacteria to be safely administered at the large dose of 2 × 10(7) colony forming units once a week i.v. with increased treatment efficacy and reduced toxicity compared to monotherapy with A1-R. The herbal mixture prevented body weight loss, spleen weight gain and liver infection by A1-R, as well as hemorrhagic lesions on the skin, liver, and spleen, all observed with A1-R monotherapy. The results of the present study suggest that the combination of A1-R and TCM has important potential for therapy of highly aggressive types of cancer, including those which are resistant to standard therapy.